Entrepreneur Dr Chris Behrenbruch on taking Telix Pharma to a billion dollars, the future of nuclear medicine and more - a podcast by Stockhead

from 2021-03-08T13:06

:: ::

This week Tim chats to Chris Behrenbruch, Bioscience Entrepreneur and CEO of Telix Pharmaceuticals Limited (ASX:TLX).

Further episodes of The Health Kick Podcast with Tim Boreham

Further podcasts by Stockhead

Website of Stockhead